# Arbor Biotechnologies

**Canonical:** https://apis.io/providers/arbor-biotechnologies/  
**Website:** https://arbor.bio/  
**APIs profiled:** 1

Arbor Biotechnologies is a next-generation gene editing company founded in 2016 by Feng Zhang, David Walt, David Scott and Winston Yan, and headquartered in Cambridge, Massachusetts. Its proprietary AI- and machine-learning-guided discovery engine has produced a toolbox of programmable DNA editors spanning knockdown, nuclease excision and compact reverse-transcriptase editing, aimed at functionally curative genomic medicines. The wholly-owned pipeline is focused on liver disease (ABO-101 for primary hyperoxaluria type 1 and ABO-103, both LNP-delivered and partnered with Chiesi Group) and CNS disease (ABO-202, ABO-203 and ABO-204 for ALS, plus ABO-206, all AAV-delivered), alongside collaborative ex vivo cell therapy programs run with Vertex, Allogene, Edigene and Chiesi. Investors include ARCH Venture Partners, Ally Bridge Group, Temasek, TCG and the Samsung Life Science Fund. Arbor operates no product or developer API and publishes no developer portal, SDKs or API documentation; its corporate site does serve the standard WordPress REST API anonymously, which makes its press releases, site pages and taxonomies machine-readable.

## Kin Score — 18.0 / 100 (emerging)

Scored 2026-08-25 under rubric 0.14.0. Trend: flat (-0.7 from 18.7).

| Facet | Score |
|---|---|
| Discoverability | 68.5 |
| Contract Quality | 13.3 |
| Governance | 16.7 |
| Contract Governance | 16.7 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 8.9 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 19.0 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | yes |
| Agentic Access | no |
| Reversibility Documented | na |
| MCP Server | no |
| Auth Clarity | bearer |
| Idempotency | na |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | derived |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | na |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## APIs (1)

- **Arbor Biotechnologies Content API (WordPress REST)** — Read-only, anonymously accessible WordPress REST API served by the Arbor Biotechnologies corporate site at https://arbor.bio/wp-json. It exposes the company's press releases and...

## Security (2)

- **Arbor Biotechnologies Authentication** — http · 1 scheme
- **Arbor Biotechnologies Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Gene Editing, CRISPR, Genomic Medicine, Life Sciences, Drug Development, Clinical Trials, Neurology, Rare Disease, Healthcare, Private Company

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/arbor-biotechnologies/). Scores are computed from the provider's own public artifacts under a published rubric.